SiSeRHMap v1.0: A simulator for mapped seismic response using a hybrid model

SiSeRHMap is a computerized methodology capable of drawing up prediction maps of seismic response. It was realized on the basis of a hybrid model which combines different approaches and models in a new and non-conventional way. These approaches 5 and models are organized in a code-architecture composed of five interdependent modules. A GIS (Geographic Information System) Cubic Model (GCM), which is a layered computational structure based on the concept of lithodynamic units and zones, aims at reproducing a parameterized layered subsoil model. A metamodeling process confers a hybrid nature to the methodology. In this process, the one-dimensional linear 10 equivalent analysis produces acceleration response spectra of shear wave velocitythickness profiles, defined as trainers, which are randomly selected in each zone. Subsequently, a numerical adaptive simulation model (Spectra) is optimized on the above trainer acceleration response spectra by means of a dedicated Evolutionary Algorithm (EA) and the Levenberg–Marquardt Algorithm (LMA) as the final optimizer. In the fi15 nal step, the GCM Maps Executor module produces a serial map-set of a stratigraphic seismic response at different periods, grid-solving the calibrated Spectra model. In addition, the spectra topographic amplification is also computed by means of a numerical prediction model. This latter is built to match the results of the numerical simulations related to isolate reliefs using GIS topographic attributes. In this way, different sets 20 of seismic response maps are developed, on which, also maps of seismic design response spectra are defined by means of an enveloping technique

Aspirin-dependent effects on purinergic P2Y1 receptor express

Chronic treatment with aspirin in healthy volunteers (HVs) is associated with recovery of adenosine diphosphate (ADP)-induced platelet activation. The purinergic P2Y1 receptor exerts its effects via a Gq-protein, which is the same biochemical pathway activated by thromboxane-A2 receptor. We hypothesized that recovery of ADP-induced platelet activation could be attributed to increased P2Y1 expression induced by chronic aspirin exposure. We performed a multi-phase investigation which embraced both in vitro and in vivo experiments conducted in (1) human megakaryoblastic DAMI cells, (2) human megakaryocytic progenitor cell cultures, (3) platelets obtained from HVs treated with aspirin and (4) platelets obtained from aspirin-treated patients. DAMI cells treated with aspirin or WY14643 (PPARα agonist) had a significant up-regulation of P2Y1 mRNA, which was shown to be a PPARα-dependent process. In human megakaryocytic progenitors, in the presence of aspirin or WY14643, P2Y1 mRNA expression was higher than in mock culture. P2Y1 expression increased in platelets obtained from HVs treated with aspirin for 8 weeks. Platelets obtained from patients who were on aspirin for more than 2 months had increased P2Y1 expression and ADP-induced aggregation compared with patients on aspirin treatment for less than a month. Overall, our results suggest that aspirin induces genomic changes in megakaryocytes leading to P2Y1 up-regulation and that PPARα is the nuclear receptor involved in this regulation. Since P2Y1 is coupled to the same Gq-protein of thromboxane-A2 receptor, platelet adaptation in response to pharmacological inhibition seems not to be receptor specific, but may involve other receptors with the same biochemical pathway

Fry Survival Rate as a Predictive Marker of Optimal Production of Silver Carp (Hypophthalmichthys molitrix, Valenciennes 1844): A Biostatistical Study in Deroua Fish Farm, Morocco

Several indicators show that the world population is rapidly increasing with prospects of reaching close to 10 billion people in 2050. Optimal production of fish is a tentative goal to ensure human feeding and resources sustainability. The present study was performed on eggs of the silver carp, collected during the breeding season of consecutive years with different environmental temperature profiles at the Deroua Fisheries Station to evaluate the seasonal and inter-seasonal changes of eggs quality in order to promote a predictive marker for optimal production of silver carp. The viability of the obtained eggs was detected using ANOVA followed by the Tukey test to analyze fertilization rate, embryos survival rate, and fry survival rate. Data analysis showed no significant difference in the fertilization and survival rate of the embryos during the two breeding seasons, and therefore these can not be used as an adequate criterion to predict the viability of the fry of silver carp. Although the survival rate of the fry did not change during the first season, it changed significantly during the second when there was an increase in the environmental temperature. This factor could be responsible for the disturbance of the females’ oogenesis and consequently the degradation of the eggs’ quality. The results showed that the fry survival rate could be used as a parameter to predict the yield of silver carp production rather than the success of fertilization and the survival of embryos. This paper discusses the importance and scope of this approach

Susceptibility mapping of shallow landslides inducing debris flows: a comparison of physics-based approaches

The assessment of timing and potential locations of rainfallinduced shallow landslides through mathematical models represents a challenge for the assessment of landslide hazard, especially in cases with limited or not available data. In fact, modeling slope hydrological response and stability requires accurate estimates of unsaturated/saturated hydraulic and geotechnical properties of materials involved in landsliding, as well as climate and topography. Such aspect is relevant for the prediction of location and timing of landslide events, which is greatly needed to reduce their catastrophic effects in terms of economic losses and casualties. To such a scope, we present the comparison of results of two physics-based models applied to the assessment of susceptibility to shallow rainfall-induced landslides in Valtellina region (northern Italy). The analyses were carried out considering effects of availability, resolution and type of data concerning spatial distribution, thickness and properties of soils coverings. For such a scope, the Transient Rainfall Infiltration and Grid-Based Regional Slope-Stability (TRIGRS) and the Climatic Rainfall Hydrogeological Modeling Experiment (CHRyME) models were considered. The study emphasizes issues in performing distributed numerical slope stability modeling depending on the availability of spatially distributed soil properties which hamper the quality of physic-based models. Further analyses aimed at the probabilistic assessment of landslide spatial distribution, related to a specific value of rainfall threshold, can be considered as potentially applicable to multi-scale landslide hazard mapping and extendable to other similar mountainous frameworks

miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models

Palbociclib is in early-stage clinical testing in advanced hepatocellular carcinoma (HCC). Here, we investigated whether the anti-tumor activity of palbociclib, which prevents the CDK4/6-mediated phosphorylation of RB1 but simultaneously activates AKT signaling, could be improved by its combination with a PI3K/AKT/mTOR inhibitor in liver cancer models. The selective pan-AKT inhibitor, MK-2206, or the microRNA-199a-3p were tested in combination with palbociclib in HCC cell lines and in the TG221 HCC transgenic mouse model. The combination palbociclib/MK-2206 was highly effective, but too toxic to be tolerated by mice. Conversely, the combination miR-199a-3p mimics/palbociclib not only induced a complete or partial regression of tumor lesions, but was also well tolerated. After 3 weeks of treatment, the combination produced a significant reduction in number and size of tumor nodules in comparison with palbociclib or miR-199a-3p mimics used as single agents. Moreover, we also reported the efficacy of this combination against sorafenib-resistant cells in vitro and in vivo. At the molecular level, the combination caused the simultaneous decrease of the phosphorylation of both RB1 and of AKT. Our findings provide pre-clinical evidence for the efficacy of the combination miR-199a-3p/palbociclib as anti-HCC treatment or as a new approach to overcome sorafenib resistance

Remote Sensing of Forest Biomass Using GNSS Reflectometry

In this study, the capability of Global Navigation Satellite System Reflectometry in evaluating forest biomass from space has been investigated by using data coming from the TechDemoSat-1 (TDS-1) mission of Surrey Satellite Technology Ltd. and from the Cyclone Satellite System (CyGNSS) mission of NASA. The analysis has been first conducted using TDS-1 data on a local scale, by selecting five test areas located in different parts of the Earth's surface. The areas were chosen as examples of various forest coverages, including equatorial and boreal forests. Then, the analysis has been extended by using CyGNSS to a global scale, including any type of forest coverage. The peak of the Delay Doppler Map calibrated to retrieve an "equivalent" reflectivity has been exploited for this investigation and its sensitivity to forest parameters has been evaluated by a direct comparison with vegetation optical depth (VOD) derived from the Soil Moisture Active Passive L-band radiometer, with a pantropical aboveground biomass (AGB) map and then with a tree height (H) global map derived from the Geoscience Laser Altimeter System installed on-board the ICEsat satellite. The sensitivity analysis confirmed the decreasing trend of the observed equivalent reflectivity for increasing biomass, with correlation coefficients 0.31 ≤ R ≤ 0.54 depending on the target parameter (VOD, AGB, or H) and on the considered dataset (local or global). These correlations were not sufficient to retrieve the target parameters by simple inversion of the direct relationships. The retrieval has been therefore based on Artificial Neural Networks making it possible to add other inputs (e.g., the incidence angle, the signal to noise ratio, and the lat/lon information in case of global maps) to the algorithm. Although not directly correlated to the biomass, these inputs helped in improving the retrieval accuracy. The algorithm was tested on both the selected areas and globally, showing a promising ability to retrieve the target parameter, either AGB or H, with correlation coefficients R ≃ 0.8

A clinical and economic evaluation of Control of Hyperglycaemia in Paediatric intensive care (CHiP): a randomised controlled trial.

BACKGROUND: Early research in adults admitted to intensive care suggested that tight control of blood glucose during acute illness can be associated with reductions in mortality, length of hospital stay and complications such as infection and renal failure. Prior to our study, it was unclear whether or not children could also benefit from tight control of blood glucose during critical illness. OBJECTIVES: This study aimed to determine if controlling blood glucose using insulin in paediatric intensive care units (PICUs) reduces mortality and morbidity and is cost-effective, whether or not admission follows cardiac surgery. DESIGN: Randomised open two-arm parallel group superiority design with central randomisation with minimisation. Analysis was on an intention-to-treat basis. Following random allocation, care givers and outcome assessors were no longer blind to allocation. SETTING: The setting was 13 English PICUs. PARTICIPANTS: Patients who met the following criteria were eligible for inclusion: ≥ 36 weeks corrected gestational age; ≤ 16 years; in the PICU following injury, following major surgery or with critical illness; anticipated treatment > 12 hours; arterial line; mechanical ventilation; and vasoactive drugs. Exclusion criteria were as follows: diabetes mellitus; inborn error of metabolism; treatment withdrawal considered; in the PICU > 5 consecutive days; and already in CHiP (Control of Hyperglycaemia in Paediatric intensive care). INTERVENTION: The intervention was tight glycaemic control (TGC): insulin by intravenous infusion titrated to maintain blood glucose between 4.0 and 7.0 mmol/l. CONVENTIONAL MANAGEMENT (CM): This consisted of insulin by intravenous infusion only if blood glucose exceeded 12.0 mmol/l on two samples at least 30 minutes apart; insulin was stopped when blood glucose fell below 10.0 mmol/l. MAIN OUTCOME MEASURES: The primary outcome was the number of days alive and free from mechanical ventilation within 30 days of trial entry (VFD-30). The secondary outcomes comprised clinical and economic outcomes at 30 days and 12 months and lifetime cost-effectiveness, which included costs per quality-adjusted life-year. RESULTS: CHiP recruited from May 2008 to September 2011. In total, 19,924 children were screened and 1369 eligible patients were randomised (TGC, 694; CM, 675), 60% of whom were in the cardiac surgery stratum. The randomised groups were comparable at trial entry. More children in the TGC than in the CM arm received insulin (66% vs. 16%). The mean VFD-30 was 23 [mean difference 0.36; 95% confidence interval (CI) -0.42 to 1.14]. The effect did not differ among prespecified subgroups. Hypoglycaemia occurred significantly more often in the TGC than in the CM arm (moderate, 12.5% vs. 3.1%; severe, 7.3% vs. 1.5%). Mean 30-day costs were similar between arms, but mean 12-month costs were lower in the TGC than in CM arm (incremental costs -£3620, 95% CI -£7743 to £502). For the non-cardiac surgery stratum, mean costs were lower in the TGC than in the CM arm (incremental cost -£9865, 95% CI -£18,558 to -£1172), but, in the cardiac surgery stratum, the costs were similar between the arms (incremental cost £133, 95% CI -£3568 to £3833). Lifetime incremental net benefits were positive overall (£3346, 95% CI -£11,203 to £17,894), but close to zero for the cardiac surgery stratum (-£919, 95% CI -£16,661 to £14,823). For the non-cardiac surgery stratum, the incremental net benefits were high (£11,322, 95% CI -£15,791 to £38,615). The probability that TGC is cost-effective is relatively high for the non-cardiac surgery stratum, but, for the cardiac surgery subgroup, the probability that TGC is cost-effective is around 0.5. Sensitivity analyses showed that the results were robust to a range of alternative assumptions. CONCLUSIONS: CHiP found no differences in the clinical or cost-effectiveness of TGC compared with CM overall, or for prespecified subgroups. A higher proportion of the TGC arm had hypoglycaemia. This study did not provide any evidence to suggest that PICUs should stop providing CM for children admitted to PICUs following cardiac surgery. For the subgroup not admitted for cardiac surgery, TGC reduced average costs at 12 months and is likely to be cost-effective. Further research is required to refine the TGC protocol to minimise the risk of hypoglycaemic episodes and assess the long-term health benefits of TGC. TRIAL REGISTRATION: Current Controlled Trials ISRCTN61735247. FUNDING: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 18, No. 26. See the NIHR Journals Library website for further project information

A molecular insight into algal-oomycete warfare : cDNA analysis of Ectocarpus siliculosus infected with the basal oomycete Eurychasma dicksonii

Peer reviewedPublisher PD

Emergence of NDM-1-producing Klebsiella pneumoniae in Guatemala

Fil: Pasteran, Fernando. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Albornoz, Ezequiel. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Faccone, Diego. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Gómez, Sonia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Valenzuela, Claudia. Unidad Central de Referencia para la Vigilancia Epidemiológica. Laboratorio Nacional de Salud. Sección Bacteriología; Guatemala.Fil: Morales, Melissa. Unidad Central de Referencia para la Vigilancia Epidemiológica. Laboratorio Nacional de Salud. Sección Bacteriología; Guatemala.Fil: Estrada, Pavela. Hospital Infantil de Infectología y Rehabilitación; Guatemala.Fil: Valenzuela, Laura. Hospital General San Juan de Dios; Ciudad de Guatemala.Fil: Matheu, Jorge. Pan American Health Organization/World Health Organization. Alert and Response and Epidemic Diseases; Estados Unidos.Fil: Guerriero, Leonor. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Arbizú, Enrique. Unidad Central de Referencia para la Vigilancia Epidemiológica. Laboratorio Nacional de Salud. Sección Bacteriología; Guatemala.Fil: Calderón, Yeraldine. Unidad Central de Referencia para la Vigilancia Epidemiológica. Laboratorio Nacional de Salud. Sección Bacteriología; Guatemala.Fil: Ramon-Pardo, Pilar. Pan American Health Organization/World Health Organization. Alert and Response and Epidemic Diseases; Estados Unidos.Fil: Corso, Alejandra. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina